Clinical Trials Directory

Trials / Completed

CompletedNCT02439255

Effect of Black Raspberry Phytochemicals on Oral Microbiome in Current Smokers and Non-smokers

Interactive Omics: Black Raspberry Metabolites and the Oral Microbiome in Smokers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
148 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This randomized clinical trial studies the effects of black raspberry compounds (phytochemicals) on the bacteria in the mouth (oral microbiome) of current smokers and non-smokers. The oral microbiome protects the body from pathogenic bacteria. Smoking alters the oral microbiome and may increase the susceptibility to cancer by modulating normal host-bacteria interactions. Black raspberry phytochemicals may protect the oral microbiome of smokers and may lower their risk of developing oral cancer.

Detailed description

PRIMARY OBJECTIVES: I. Determine the effect of black raspberry phytochemicals on community dynamics within oral biofilms. II. Examine the effect of oral bacterial communities on metabolism of black raspberry phytochemicals in current and never smokers. III. Evaluate the efficacy of black raspberry phytochemicals and their metabolites in reversing the effect of smoking on oral host-microbial interactions. OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants receive bioactivity of black raspberry phytochemical-rich delivery vehicle (BRB nectar) orally (PO) once daily (QD) for 12 weeks. ARM II: Participants receive placebo nectar PO QD for 12 weeks.

Conditions

Interventions

TypeNameDescription
OTHERLaboratory Biomarker AnalysisCorrelative studies
DIETARY_SUPPLEMENTPhytochemicalGiven black raspberry (BRB) nectar per oral (PO)
OTHERPlaceboGiven PO
OTHERScreening Questionnaire AdministrationAncillary studies

Timeline

Start date
2015-12-04
Primary completion
2018-06-30
Completion
2022-04-30
First posted
2015-05-08
Last updated
2022-10-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02439255. Inclusion in this directory is not an endorsement.